Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer (Q36597012)
Jump to navigation
Jump to search
scientific article published on 26 November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer |
scientific article published on 26 November 2007 |
Statements
1 reference
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer (English)
1 reference
Gillian Thomas
1 reference
Shamshad Ali
1 reference
Frank J P Hoebers
1 reference
Kathleen M Darcy
1 reference
William H Rodgers
1 reference
Malti Patel
1 reference
Ovardia Abulafia
1 reference
Joseph A Lucci
1 reference
Adrian C Begg
1 reference
26 November 2007
1 reference
1 reference
317-325
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference